The role of chemokines in experimental thyroiditis
趋化因子在实验性甲状腺炎中的作用
基本信息
- 批准号:7461004
- 负责人:
- 金额:$ 35.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-01 至 2013-04-30
- 项目状态:已结题
- 来源:
- 关键词:Autoimmune ProcessBlood VesselsCCL21 geneCellsDataDendritic CellsDevelopmentHigh Endothelial VenuleHumanImmuneImmune systemLinkLymphatic VenulesLymphocyteLymphoid FollicleMusPathogenesisReportingRoleSolidStructureThyroid DiseasesThyroid GlandThyroiditisTransgenic ModelWorkautoimmune thyroid diseasechemokinereceptor
项目摘要
DESCRIPTION (provided by applicant): Solid experimental data links human autoimmune thyroid disease (AITD) and expression of chemokines, but the studies to date have been mostly descriptive. We have developed transgenic models to investigate the role of chemokines in AITD. We have reported that expression of CCL21, a chemokine expressed in AITD, leads to recruitment of lymphocytes and dendritic cells (DC) into the thyroid. As is found in AITD, lymphocytes organize in structures resembling lymphoid follicles, in which vascular structures such as high endothelial venules (HEV) and lymphatics are present. Deletion of CCR7, the receptor for CCL21, in the autoimmune-prone NOD background favors development of thyroiditis, suggesting a regulatory role for CCL21 in AITD. Our specific aims in this proposal are: 1) to define the mechanisms favoring the formation of thyroid lymphoid follicles, and their relevance to development of EAT; and 2), to define the mechanisms favoring development of thyroiditis in NODCCR7ko/ko mice. Many types of thyroid diseases are caused by destruction of the cells of the thyroid by cells of the immune system.
PUBLLIC HEALTH RELEVANCE: We will investigate the mechanisms whereby these immune cells arrive in the thyroid and will determine if blocking some of these mechanisms will alter thyroid disease. This work should define the role of immune components in the pathogenesis of thyroid diseases.
描述(由申请人提供):可靠的实验数据将人类自身免疫性甲状腺疾病(AITD)与趋化因子的表达联系起来,但迄今为止的研究大多是描述性的。我们已经开发了转基因模型来研究趋化因子在AITD中的作用。我们已经报道了在AITD中表达的趋化因子CCL 21的表达导致淋巴细胞和树突状细胞(DC)募集到甲状腺中。如在AITD中所发现的,淋巴细胞以类似淋巴滤泡的结构组织,其中存在血管结构如高内皮小静脉(HEV)和微血管。CCL 21的受体CCR 7在自身免疫易感NOD背景中的缺失有利于甲状腺炎的发展,表明CCL 21在AITD中的调节作用。我们的具体目标是:1)确定有利于甲状腺淋巴滤泡形成的机制,以及它们与EAT发展的相关性; 2)确定有利于NODCCR 7 ko/ko小鼠甲状腺炎发展的机制。许多类型的甲状腺疾病是由免疫系统细胞破坏甲状腺细胞引起的。
公共卫生相关性:我们将研究这些免疫细胞到达甲状腺的机制,并确定阻断其中一些机制是否会改变甲状腺疾病。这项工作应确定免疫成分在甲状腺疾病发病机制中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SERGIO A. LIRA其他文献
SERGIO A. LIRA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SERGIO A. LIRA', 18)}}的其他基金
Mechanisms associated with diet-induced colitis
饮食诱发结肠炎的相关机制
- 批准号:
10093034 - 财政年份:2020
- 资助金额:
$ 35.36万 - 项目类别:
Mechanisms associated with diet-induced colitis
饮食诱发结肠炎的相关机制
- 批准号:
10553265 - 财政年份:2020
- 资助金额:
$ 35.36万 - 项目类别:
Mechanisms associated with diet-induced colitis
饮食诱发结肠炎的相关机制
- 批准号:
10339359 - 财政年份:2020
- 资助金额:
$ 35.36万 - 项目类别:
Mechanisms associated with flares and remission in colitis
结肠炎发作和缓解的相关机制
- 批准号:
9922284 - 财政年份:2017
- 资助金额:
$ 35.36万 - 项目类别:
Mechanisms associated with flares and remission in colitis
结肠炎发作和缓解的相关机制
- 批准号:
10623214 - 财政年份:2017
- 资助金额:
$ 35.36万 - 项目类别:
Mechanisms associated with flares and remission in colitis
结肠炎发作和缓解的相关机制
- 批准号:
10438874 - 财政年份:2017
- 资助金额:
$ 35.36万 - 项目类别:
Mechanisms associated with flares and remission in colitis
结肠炎发作和缓解的相关机制
- 批准号:
10297538 - 财政年份:2017
- 资助金额:
$ 35.36万 - 项目类别:
Molecular pathogenesis of intestinal serrated polyps
肠锯齿状息肉的分子发病机制
- 批准号:
8519092 - 财政年份:2011
- 资助金额:
$ 35.36万 - 项目类别:
Molecular pathogenesis of intestinal serrated polyps
肠锯齿状息肉的分子发病机制
- 批准号:
8706828 - 财政年份:2011
- 资助金额:
$ 35.36万 - 项目类别:
相似海外基金
A methodology to connect functionalized gonadal constructs to a chick embryo through mechanically induced blood vessels from an egg
一种通过鸡蛋机械诱导血管将功能化性腺结构连接到鸡胚胎的方法
- 批准号:
24K15741 - 财政年份:2024
- 资助金额:
$ 35.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
All-in-One Smart Artificial Blood Vessels
一体化智能人造血管
- 批准号:
EP/X027171/2 - 财政年份:2024
- 资助金额:
$ 35.36万 - 项目类别:
Fellowship
Development of nextgeneration cellular artificial blood vessels for coronary artery bypass surgery using bio-3D printer
使用生物 3D 打印机开发用于冠状动脉搭桥手术的下一代细胞人造血管
- 批准号:
23H02991 - 财政年份:2023
- 资助金额:
$ 35.36万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
ealization of navigation surgery by automatic recognition of stomach and surrounding blood vessels using artificial intelligence
利用人工智能自动识别胃及周围血管,实现导航手术
- 批准号:
23K07176 - 财政年份:2023
- 资助金额:
$ 35.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Realtime observation and optical control of living microbial probes in blood vessels
血管内活微生物探针的实时观察和光学控制
- 批准号:
23H00551 - 财政年份:2023
- 资助金额:
$ 35.36万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Creation of a technique for visualization of stress concentration in blood and blood vessels by combined measurement of photoelasticity and ultrasonic Doppler velocimetry
通过光弹性和超声多普勒测速的组合测量,创建了一种可视化血管中应力集中的技术
- 批准号:
23H01343 - 财政年份:2023
- 资助金额:
$ 35.36万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Shear stress-activated synthetic cells for targeted drug release in stenotic blood vessels
剪切应力激活合成细胞用于狭窄血管中的靶向药物释放
- 批准号:
10749217 - 财政年份:2023
- 资助金额:
$ 35.36万 - 项目类别:
Creation of 3D tissue culture system integrated with blood vessels and autonomic nerves
打造血管与植物神经融合的3D组织培养系统
- 批准号:
23H01827 - 财政年份:2023
- 资助金额:
$ 35.36万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Biological function of osteoporotic drugs on bone-specific blood vessels and perivascular cells
骨质疏松药物对骨特异性血管和血管周围细胞的生物学功能
- 批准号:
22K21006 - 财政年份:2022
- 资助金额:
$ 35.36万 - 项目类别:
Grant-in-Aid for Research Activity Start-up














{{item.name}}会员




